The Patent Finder

Vettore, LLC

53 patents currently held · Updated Nov 21, 2026
20 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 15, 2027
    The maintenance fee for MCT4 Inhibitors for Treating Disease (US 11,724,989) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 1 fee due Mar 19, 2027
    The maintenance fee for Jet milling method (US 11,759,791) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
  • 1 fee due May 21, 2027
    The maintenance fee for Treating inflammation with inhaled aspirin (US 11,819,569) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 1 fee due Jun 17, 2027
    The maintenance fee for Polymorphs (US 10,508,123) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
  • 2 fees due Jul 9 to 14, 2027 · next Jul 9
  • 1 fee due Nov 19, 2027
    The maintenance fee for Solvent-free gadolinium contrast agents (US 10,653,804) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,582,789Hearing enhancement systems
In force
 · USPTO record
In forceUSPTO record
US 7,677,723Eyeglasses with a heart rate monitor
In force
 · USPTO record
In forceUSPTO record
US 8,182,838Dry powder composition comprising co-jet milled particles for pulmonary inhalation
In force
 · USPTO record
In forceUSPTO record
US D742,503Mobile inhaler device
In force
 · USPTO record
In forceUSPTO record
US 9,381,189Ingredients for inhalation and methods for making the same
In force
 · USPTO record
In forceUSPTO record
US 10,821,116Administration of iloprost as aerosol bolus
In force
 · USPTO record
In forceUSPTO record
US 9,589,214Apparatus and methods for dispensing at least one segment of a printed media sheet with a plurality of segments
In force
 · USPTO record
In forceUSPTO record
US 12,251,506Mixing channel for an inhalation device and inhalation device
In force
 · USPTO record
In forceUSPTO record
US 11,819,569Treating inflammation with inhaled aspirin
In force
 · USPTO record
In forceUSPTO record
US 11,865,210Dry powder formulations and methods of use
In force
 · USPTO record
In forceUSPTO record
10 of 53 patents shown.
Pro members see all 53.
Pro members: see all 53 patents
Also on record, not counted in the 53: 20 patents in force now held by others · 67 lapsed for an unpaid fee · 181 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 4 abandoned · 43 no status recorded

Showing 1 to 10 of 56, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/047,401Salts of Heterocyclic Inhibitors of Monocarboxylate Transporter 4 for the Treatment of DiseaseFeb 6, 2025Pending
19/047,396Methods and Processes for the Preparation of MCT4 InhibitorsFeb 6, 2025Pending
18/958,610MCT4 Inhibitors for Treating DiseaseNov 25, 2024Pending
18/794,861Lanthanide-Based Contrast Agents Having Improved Stability and Methods for Their Production and PurificationAug 5, 2024Pending
18/595,185Farmed Fish Tracking and Verification SystemMar 4, 2024Pending
18/537,462Metastable-Free Lanthanide Based Contrast Agents and MethodDec 12, 2023Pending
18/868,815An Inhaler Comprising a Retention ElementJul 19, 2023Pending
18/352,410Cocrystals of Nicotinamide Riboside Salts, Crystalline Forms, Methods of Preparation, and Applications ThereofJul 14, 2023Pending
17/891,391Reduced Metastable Complex Macrocyclic Contrast AgentsAug 19, 2022Pending
17/701,021Mar 22, 2022No status recorded
10 of 56 applications shown.
Pro members see all 56 published applications.
Pro members: see all 56 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited